The NIR-pCLE imaging results were confirmed with Odyssey CLx imaging, showing PSMA-specific tumor uptake of PSMA-914 accompanied by non-target uptake in liver and kidneys, marking the excretion route (Figure 4, Supplemental Figure S4). Here, FOLH1 is linked to neoplasm.